Steroidal triterpenes of cholesterol synthesis

Molecules

Volumn 18, Issue 4, 2013, Pages 4002-4017

  Ačimovič, Jure ^a   Rozman, Damjana ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cholesterol synthesis; Post squalene pathway; Steroidal triterpenes; Sterols

Indexed keywords

CHOLESTEROL; LANOSTEROL; SQUALENE; STEROID; STEROL; TRITERPENE;

ANIMAL; ANIMAL MODEL; BIOSYNTHESIS; CHEMISTRY; METABOLOMICS; METHODOLOGY; REVIEW;

ANIMALS; CHOLESTEROL; LANOSTEROL; METABOLOMICS; MODELS, ANIMAL; SQUALENE; STEROIDS; STEROLS; TRITERPENES;

EID: 84876749084     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18044002     Document Type: Review

References (55)

1. Goldstein, J.L.; Brown, M.S. Regulation of the Mevalonate Pathway. Nature 1990, 343, 425-430.
2. Griffiths, W.J.; Wang, Y. Analysis of neurosterols by GC-MS and LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 2778-2805.
3. Porter, F.D. Malformation syndromes due to inborn errors of cholesterol synthesis. J. Clin. Invest. 2002, 110, 715-724.
4. Horvat, S.; McWhir, J.; Rozman, D. Defects in cholesterol synthesis genes in mouse and in humans: lessons for drug development and safer treatments. Drug Metab. Rev. 2011, 43, 69-90.
5. Kandutsch, A.A.; Russell, A.E. Preputial gland tumor sterols. 3. A metabolic pathway from lanosterol to cholesterol. J. Biol. Chem. 1960, 235, 2256-2261.
6. Marijanovic, Z.; Laubner, D.; Moller, G.; Gege, C.; Husen, B.; Adamski, J.; Breitling, R. Closing the gap: identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis. Mol. Endocrinol. 2003, 17, 1715-1725.
7. Bae, S.H.; Paik, Y.K. Cholesterol biosynthesis from lanosterol: development of a novel assay method and characterization of rat liver microsomal lanosterol delta 24-reductase. Biochem. J. 1997, 326, 609-616.
8. Liu, J.; Nes, W.D. Steroidal triterpenes: design of substrate-based inhibitors of ergosterol and sitosterol synthesis. Molecules 2009, 14, 4690-4706.
9. Goad, L.J.; Akishisa, T. Analysis of Sterols; Blackie Academic & Professional: London, UK, 1997; Chapter 1, p. 20.
10. Bloch, K.; Gautschi, F.; Johnston, J.D. Isolation of lanosterol from isocholesterol. J. Biol. Chem. 1957, 224, 185-190.
11. Kandutsch, A.A.; Russell, A.E. Preputial gland tumor sterols. I. The occurrence of 24,25- dihydrolanosterol and a comparison with liver and the normal gland. J. Biol. Chem. 1959, 234, 2037-2042.
12. Byskov, A.G.; Andersen, C.Y.; Nordholm, L.; Thogersen, H.; Xia, G.; Wassmann, O.; Andersen, J.V.; Guddal, E.; Roed, T. Chemical structure of sterols that activate oocyte meiosis. Nature 1995, 374, 559-562.
13. Ruan, B.; Watanabe, S.; Eppig, J.J.; Kwoh, C.; Dzidic, N.; Pang, J.; Wilson, W.K.; Schroepfer, G.J., Jr. Sterols affecting meiosis: novel chemical syntheses and the biological activity and spectral properties of the synthetic sterols. J. Lipid Res. 1998, 39, 2005-2020.
14. Murray, A.; Gronvald, F.C.; Nielsen, J.K.; Faarup, P. Synthesis of FF-MAS from lithocholic acid. Bioorg. Med. Chem. Lett. 2000, 10, 1067-1068.
15. Ruan, B.; Wilson, W.K.; Schroepfer, G.J., Jr. An alternative synthesis of 4,4-dimethyl-5 alphacholesta- 8,14,24-trien-3 beta-ol, an intermediate in sterol biosynthesis and a reported activator of meiosis and of nuclear orphan receptor LXR alpha. Bioorg. Med. Chem. Lett. 1998, 8, 233-236.
16. Schroepfer, G.J., Jr.; Parish, E.J.; Tsuda, M.; Kandutsch, A.A. Inhibitors of sterol synthesis. Chemical syntheses, properties and effects of 4,4-dimethyl-15-oxygenated sterols on sterol synthesis and on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured mammalian cells. Chem. Phys. Lipids 1988, 47, 187-207.
17. Thoma, R.; Schulz-Gasch, T.; D'Arcy, B.; Benz, J.; Aebi, J.; Dehmlow, H.; Hennig, M.; Stihle, M.; Ruf, A. Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase. Nature 2004, 432, 118-122.
18. Wendt, K.U.; Schulz, G.E.; Corey, E.J.; Liu, D.R., Enzyme Mechanisms for Polycyclic Triterpene Formation. Angew. Chem. Int. Ed. Engl. 2000, 39, 2812-2833.
19. Debeljak, N.; Fink, M.; Rozman, D. Many facets of mammalian lanosterol 14alpha-demethylase from the evolutionarily conserved cytochrome P450 family CYP51. Arch. Biochem. Biophys. 2003, 409, 159-171.
20. Bennati, A.M.; Schiavoni, G.; Franken, S.; Piobbico, D.; Della Fazia, M.A.; Caruso, D.; de Fabiani, E.; Benedetti, L.; Cusella De Angelis, M.G.; Gieselmann, V.; et al. Disruption of the gene encoding 3beta-hydroxysterol Delta-reductase (Tm7sf2) in mice does not impair cholesterol biosynthesis. FEBS J. 2008, 275, 5034-5047.
21. Wassif, C.A.; Brownson, K.E.; Sterner, A.L.; Forlino, A.; Zerfas, P.M.; Wilson, W.K.; Starost, M.F.; Porter, F.D. HEM dysplasia and ichthyosis are likely laminopathies and not due to 3betahydroxysterol Delta14-reductase deficiency. Hum. Mol. Genet. 2007, 16, 1176-1187.
22. Moebius, F.F.; Fitzky, B.U.; Lee, J.N.; Paik, Y.K.; Glossmann, H. Molecular cloning and expression of the human delta7-sterol reductase. Proc. Natl. Acad. Sci. USA 1998, 95, 1899-1902.
23. Bae, S.H.; Lee, J.N.; Fitzky, B.U.; Seong, J.; Paik, Y.K. Cholesterol biosynthesis from lanosterol. Molecular cloning, tissue distribution, expression, chromosomal localization, and regulation of rat 7-dehydrocholesterol reductase, a Smith-Lemli-Opitz syndrome-related protein. J. Biol. Chem. 1999, 274, 14624-14631.
24. Rozman, D.; Monostory, K. Perspectives of the non-statin hypolipidemic agents. Pharmacol. Ther. 2010, 127, 19-40.
25. Nitahara, Y.; Aoyama, Y.; Horiuchi, T.; Noshiro, M.; Yoshida, Y. Purification and characterization of rat sterol 14-demethylase P450 (CYP51) expressed in Escherichia coli. J. Biochem. 1999, 126, 927-933.
26. Paik, Y.K.; Trzaskos, J.M.; Shafiee, A.; Gaylor, J.L. Microsomal enzymes of cholesterol biosynthesis from lanosterol. Characterization, solubilization, and partial purification of NADPH-dependent delta 8,14-steroid 14-reductase. J. Biol. Chem. 1984, 259, 13413-13423.
27. Moebius, F.F.; Reiter, R.J.; Bermoser, K.; Glossmann, H.; Cho, S.Y.; Paik, Y.K. Pharmacological analysis of sterol delta8-delta7 isomerase proteins with [3H]ifenprodil. Mol. Pharmacol. 1998, 54, 591-598.
28. Takakuwa, Y.; Nishino, H.; Ishibe, Y.; Ishibashi, T. Properties and kinetics of membrane-bound enzymes when both the enzyme and substrate are components of the same microsomal membrane. Studies on lathosterol 5-desaturase. J. Biol. Chem. 1994, 269, 27889-27893.
29. Kelley, R.I.; Hennekam, R.C. The Smith-Lemli-Opitz syndrome. J. Med. Genet. 2000, 37, 321-335.
30. Waterham, H.R.; Koster, J.; Romeijn, G.J.; Hennekam, R.C.; Vreken, P.; Andersson, H.C.; FitzPatrick, D.R.; Kelley, R.I.; Wanders, R.J. Mutations in the 3beta-hydroxysterol Delta24- reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am. J. Hum. Genet. 2001, 69, 685-694.
31. Brunetti-Pierri, N.; Corso, G.; Rossi, M.; Ferrari, P.; Balli, F.; Rivasi, F.; Annunziata, I.; Ballabio, A.; Russo, A.D.; Andria, G.; et al. Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3beta-hydroxysteroid-delta5-desaturase. Am. J. Hum. Genet. 2002, 71, 952-958.
32. Krakowiak, P.A.; Wassif, C.A.; Kratz, L.; Cozma, D.; Kovarova, M.; Harris, G.; Grinberg, A.; Yang, Y.; Hunter, A.G.; Tsokos, M.; et al. Lathosterolosis: An inborn error of human and murine cholesterol synthesis due to lathosterol 5-desaturase deficiency. Hum. Mol. Genet. 2003, 12, 1631-1641.
33. Waterham, H.R.; Koster, J.; Mooyer, P.; Noort Gv, G.; Kelley, R.I.; Wilcox, W.R.; Wanders, R.J.; Hennekam, R.C.; Oosterwijk, J.C. Autosomal recessive HEM/Greenberg skeletal dysplasia is caused by 3 beta-hydroxysterol delta 14-reductase deficiency due to mutations in the lamin B receptor gene. Am. J. Hum. Genet. 2003, 72, 1013-1017.
34. Konig, A.; Happle, R.; Bornholdt, D.; Engel, H.; Grzeschik, K.H. Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. Am. J. Med. Genet. 2000, 90, 339-346.
35. Braverman, N.; Lin, P.; Moebius, F.F.; Obie, C.; Moser, A.; Glossmann, H.; Wilcox, W.R.; Rimoin, D.L.; Smith, M.; Kratz, L.; et al. Mutations in the gene encoding 3 beta-hydroxysteroiddelta 8, delta 7-isomerase cause X-linked dominant Conradi-Hunermann syndrome. Nat. Genet. 1999, 22, 291-294.
36. Bloch, K.E. Sterol structure and membrane function. CRC Crit. Rev. Biochem. 1983, 14, 47-92.
37. Voet, D.; Voet, J.G. Biochemistry, 4th ed.; John Wiley & Sons: Hoboken, NJ, USA, 2011; Chapter 25, pp. 951-954.
38. Tulenko, T.N.; Boeze-Battaglia, K.; Mason, R.P.; Tint, G.S.; Steiner, R.D.; Connor, W.E.; Labelle, E.F. A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome. J. Lipid Res. 2006, 47, 134-143.
39. Song, B.L.; Javitt, N.B.; DeBose-Boyd, R.A. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metab. 2005, 1, 179-189.
40. Goldstein, J.L.; DeBose-Boyd, R.A.; Brown, M.S. Protein sensors for membrane sterols. Cell 2006, 124, 35-46.
41. Fitzky, B.U.; Moebius, F.F.; Asaoka, H.; Waage-Baudet, H.; Xu, L.; Xu, G.; Maeda, N.; Kluckman, K.; Hiller, S.; Yu, H.; et al. 7-Dehydrocholesterol- dependent proteolysis of HMGCoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J. Clin. Invest. 2001, 108, 905-915.
42. Byskov, A.G.; Andersen, C.Y.; Leonardsen, L.; Baltsen, M. Meiosis activating sterols (MAS) and fertility in mammals and man. J. Exp. Zool. 1999, 285, 237-242.
43. Vaknin, K.M.; Lazar, S.; Popliker, M.; Tsafriri, A. Role of meiosis-activating sterols in rat oocyte maturation: effects of specific inhibitors and changes in the expression of lanosterol 14alphademethylase during the preovulatory period. Biol. Reprod.2001, 64, 299-309.
44. Grondahl, C. Oocyte maturation. Basic and clinical aspects of in vitro maturation (IVM) with special emphasis of the role of FF-MAS. Dan. Med. Bull. 2008, 55, 1-16.
45. Keber, R.; Rozman, D.; Horvat, S. Sterols in spermatogenesis and sperm maturation. J. Lipid Res. 2013, 54, 20-33.
46. Connor, W.E.; Lin, D.S.; Neuringer, M. Biochemical markers for puberty in the monkey testis: desmosterol and docosahexaenoic acid. J. Clin. Endocrinol. Metab. 1997, 82, 1911-1916.
47. Acimovic, J.; Kosir, R.; Kastelec, D.; Perse, M.; Majdic, G.; Rozman, D.; Kosmelj, K.; Golicnik, M. Circadian rhythm of cholesterol synthesis in mouse liver: A statistical analysis of the post-squalene metabolites in wild-type and Crem-knock-out mice. Biochem. Biophys. Res. Commun. 2011, 408, 635-641.
48. Ali, Z.; Heverin, M.; Olin, M.; Acimovic, J.; Lovgren-Sandblom, A.; Shafaati, M.; Bavner, A.; Meiner, V.; Leitersdorf, E.; Bjorkhem, I. On the regulatory role of side-chain hydroxylated oxysterols in the brain. Lessons from CYP27A1 transgenic and cyp27a1-/- mice. J. Lipid Res. 2013, 54,1033-1043.
49. Bjorkhem-Bergman, L.; Acimovic, J.; Torndal, U.B.; Parini, P.; Eriksson, L.C. Lovastatin prevents carcinogenesis in a rat model for liver cancer. Effects of ubiquinone supplementation. Anticancer Res. 2010, 30, 1105-1112.
50. Tacer, K.F.; Haugen, T.B.; Baltsen, M.; Debeljak, N.; Rozman, D. Tissue-specific transcriptional regulation of the cholesterol biosynthetic pathway leads to accumulation of testis meiosisactivating sterol (T-MAS). J. Lipid Res. 2002, 43, 82-89.
51. Xu, F.; Rychnovsky, S.D.; Belani, J.D.; Hobbs, H.H.; Cohen, J.C.; Rawson, R.B. Dual roles for cholesterol in mammalian cells. Proc. Natl. Acad. Sci. USA 2005, 102, 14551-14556.
52. Rodriguez-Acebes, S.; de la Cueva, P.; Fernandez-Hernando, C.; Ferruelo, A.J.; Lasuncion, M.A.; Rawson, R.B.; Martinez-Botas, J.; Gomez-Coronado, D. Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductasedeficient cell line. Biochem. J. 2009, 420, 305-315.
53. Flaxman, N. Mer-29 (Triparanol) and Cataract. Med. Trial Tech. Q. 1963, 10, 11-32.
54. Kirby, T.J. Cataracts produced by triparanol. (MER-29). Trans. Am. Ophthalmol. Soc. 1967, 65, 494-543.
55. Perdriel, G. Cataract and Triparanol. Bull. Soc. Ophtalmol. Fr. 1964, 64, 699-701.